Skip to main content
SpringerLink
Log in

Einfluss einer Therapie mit IFN β-1b auf Oligodendrozytenvorläuferzellen

Influence of therapy with interferon β 1b on oligodendrocyte precursor cells

  • Abstracts
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Forschungsunterstützung: Bayer Vital GmbH/Bayer Schering Pharma AG. Vertragshonorar, Reisekostenerstattung: BiogenIdec, MerckSerono, Sanofi-Aventis, Forschungsunterstützung: BiogenIdec.

Author information

Authors and Affiliations

  1. Neurologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland

    A. Kotsiari, E. Voß  &  M. Stangel

Authors
  1. A. Kotsiari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Voß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stangel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Stangel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotsiari, A., Voß , E. & Stangel, M. Einfluss einer Therapie mit IFN β-1b auf Oligodendrozytenvorläuferzellen. Nervenarzt 80 (Suppl 1), 42–43 (2009). https://doi.org/10.1007/s00115-009-2775-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-009-2775-4

Search

Navigation